aluates Reports

$ 0.0

Automative

Global Prostate Cancer Medicine Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-5C3032

Global Prostate Cancer Medicine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Prostate Cancer Medicine Market Insights, Forecast to 2030

Code: QYRE-Auto-5C3032

Report

December 2024

Pages:113

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Active Biotech

Bristol–Myers Squibb

Teva Pharmaceuticals Industries Ltd

Johnson & Johnson

Pfizer Inc

Bayer

Abbott Laboratories

Astellas Pharma Inc

Roche Holding AG

Prostate Cancer Medicine Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Prostate Cancer Medicine Market

Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. This cancer develops slowly, with no early detectable symptoms for many years. The precise cause of prostate cancer is unknown; however, factors such as obesity, high calcium diet, lack of exercise, ethnicity (African American men), and old age contribute to its occurrence.

Market Analysis and Insights: Global Prostate Cancer Medicine Market

The global Prostate Cancer Medicine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Covers:

This report presents an overview of global market for Prostate Cancer Medicine market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Prostate Cancer Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prostate Cancer Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prostate Cancer Medicine revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prostate Cancer Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prostate Cancer Medicine revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Prostate Cancer Medicine Market Report

Report Metric	Details
Report Name	Prostate Cancer Medicine Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	LHRH Antagonists LHRH Analogs Antiandrogens Pipeline Drugs for Hormonal Therapy
Segment by Application	Age Below 55 Age 55-75 Age Above 75
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca plc, Active Biotech, Bristol Myers-Squibb, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Pfizer Inc., Bayer AG, Abbott Laboratories, Astellas Pharma Inc., Roche Holding AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prostate Cancer Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prostate Cancer Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prostate Cancer Medicine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Prostate Cancer Medicine Market report?

Ans: The main players in the Prostate Cancer Medicine Market are AstraZeneca plc, Active Biotech, Bristol Myers-Squibb, Teva Pharmaceuticals Industries Ltd., Johnson & Johnson, Pfizer Inc., Bayer AG, Abbott Laboratories, Astellas Pharma Inc., Roche Holding AG

What are the Application segmentation covered in the Prostate Cancer Medicine Market report?

Ans: The Applications covered in the Prostate Cancer Medicine Market report are Age Below 55, Age 55-75, Age Above 75

What are the Type segmentation covered in the Prostate Cancer Medicine Market report?

Ans: The Types covered in the Prostate Cancer Medicine Market report are LHRH Antagonists, LHRH Analogs, Antiandrogens, Pipeline Drugs for Hormonal Therapy

Recommended Reports

Prostate Cancer Solutions

Medical Devices & Equipment

General Healthcare Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Prostate Cancer Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 LHRH Antagonists

1.2.3 LHRH Analogs

1.2.4 Antiandrogens

1.2.5 Pipeline Drugs for Hormonal Therapy

1.3 Market by Application

1.3.1 Global Prostate Cancer Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Age Below 55

1.3.3 Age 55-75

1.3.4 Age Above 75

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Prostate Cancer Medicine Market Perspective (2019-2030)

2.2 Global Prostate Cancer Medicine Growth Trends by Region

2.2.1 Prostate Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Prostate Cancer Medicine Historic Market Size by Region (2019-2024)

2.2.3 Prostate Cancer Medicine Forecasted Market Size by Region (2025-2030)

2.3 Prostate Cancer Medicine Market Dynamics

2.3.1 Prostate Cancer Medicine Industry Trends

2.3.2 Prostate Cancer Medicine Market Drivers

2.3.3 Prostate Cancer Medicine Market Challenges

2.3.4 Prostate Cancer Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Prostate Cancer Medicine by Players

3.1.1 Global Prostate Cancer Medicine Revenue by Players (2019-2024)

3.1.2 Global Prostate Cancer Medicine Revenue Market Share by Players (2019-2024)

3.2 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Prostate Cancer Medicine, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Prostate Cancer Medicine Market Concentration Ratio

3.4.1 Global Prostate Cancer Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Medicine Revenue in 2023

3.5 Global Key Players of Prostate Cancer Medicine Head office and Area Served

3.6 Global Key Players of Prostate Cancer Medicine, Product and Application

3.7 Global Key Players of Prostate Cancer Medicine, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Medicine Breakdown Data by Type

4.1 Global Prostate Cancer Medicine Historic Market Size by Type (2019-2024)

4.2 Global Prostate Cancer Medicine Forecasted Market Size by Type (2025-2030)

5 Prostate Cancer Medicine Breakdown Data by Application

5.1 Global Prostate Cancer Medicine Historic Market Size by Application (2019-2024)

5.2 Global Prostate Cancer Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Prostate Cancer Medicine Market Size (2019-2030)

6.2 North America Prostate Cancer Medicine Market Size by Type

6.2.1 North America Prostate Cancer Medicine Market Size by Type (2019-2024)

6.2.2 North America Prostate Cancer Medicine Market Size by Type (2025-2030)

6.2.3 North America Prostate Cancer Medicine Market Share by Type (2019-2030)

6.3 North America Prostate Cancer Medicine Market Size by Application

6.3.1 North America Prostate Cancer Medicine Market Size by Application (2019-2024)

6.3.2 North America Prostate Cancer Medicine Market Size by Application (2025-2030)

6.3.3 North America Prostate Cancer Medicine Market Share by Application (2019-2030)

6.4 North America Prostate Cancer Medicine Market Size by Country

6.4.1 North America Prostate Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Prostate Cancer Medicine Market Size by Country (2019-2024)

6.4.3 North America Prostate Cancer Medicine Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Prostate Cancer Medicine Market Size (2019-2030)

7.2 Europe Prostate Cancer Medicine Market Size by Type

7.2.1 Europe Prostate Cancer Medicine Market Size by Type (2019-2024)

7.2.2 Europe Prostate Cancer Medicine Market Size by Type (2025-2030)

7.2.3 Europe Prostate Cancer Medicine Market Share by Type (2019-2030)

7.3 Europe Prostate Cancer Medicine Market Size by Application

7.3.1 Europe Prostate Cancer Medicine Market Size by Application (2019-2024)

7.3.2 Europe Prostate Cancer Medicine Market Size by Application (2025-2030)

7.3.3 Europe Prostate Cancer Medicine Market Share by Application (2019-2030)

7.4 Europe Prostate Cancer Medicine Market Size by Country

7.4.1 Europe Prostate Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Prostate Cancer Medicine Market Size by Country (2019-2024)

7.4.3 Europe Prostate Cancer Medicine Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Prostate Cancer Medicine Market Size (2019-2030)

8.2 China Prostate Cancer Medicine Market Size by Type

8.2.1 China Prostate Cancer Medicine Market Size by Type (2019-2024)

8.2.2 China Prostate Cancer Medicine Market Size by Type (2025-2030)

8.2.3 China Prostate Cancer Medicine Market Share by Type (2019-2030)

8.3 China Prostate Cancer Medicine Market Size by Application

8.3.1 China Prostate Cancer Medicine Market Size by Application (2019-2024)

8.3.2 China Prostate Cancer Medicine Market Size by Application (2025-2030)

8.3.3 China Prostate Cancer Medicine Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Prostate Cancer Medicine Market Size (2019-2030)

9.2 Asia Prostate Cancer Medicine Market Size by Type

9.2.1 Asia Prostate Cancer Medicine Market Size by Type (2019-2024)

9.2.2 Asia Prostate Cancer Medicine Market Size by Type (2025-2030)

9.2.3 Asia Prostate Cancer Medicine Market Share by Type (2019-2030)

9.3 Asia Prostate Cancer Medicine Market Size by Application

9.3.1 Asia Prostate Cancer Medicine Market Size by Application (2019-2024)

9.3.2 Asia Prostate Cancer Medicine Market Size by Application (2025-2030)

9.3.3 Asia Prostate Cancer Medicine Market Share by Application (2019-2030)

9.4 Asia Prostate Cancer Medicine Market Size by Region

9.4.1 Asia Prostate Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Prostate Cancer Medicine Market Size by Region (2019-2024)

9.4.3 Asia Prostate Cancer Medicine Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Type

10.2.1 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Application

10.3.1 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Country

10.4.1 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AstraZeneca plc

11.1.1 AstraZeneca plc Company Details

11.1.2 AstraZeneca plc Business Overview

11.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction

11.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2019-2024)

11.1.5 AstraZeneca plc Recent Developments

11.2 Active Biotech

11.2.1 Active Biotech Company Details

11.2.2 Active Biotech Business Overview

11.2.3 Active Biotech Prostate Cancer Medicine Introduction

11.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2019-2024)

11.2.5 Active Biotech Recent Developments

11.3 Bristol Myers-Squibb

11.3.1 Bristol Myers-Squibb Company Details

11.3.2 Bristol Myers-Squibb Business Overview

11.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction

11.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2019-2024)

11.3.5 Bristol Myers-Squibb Recent Developments

11.4 Teva Pharmaceuticals Industries Ltd.

11.4.1 Teva Pharmaceuticals Industries Ltd. Company Details

11.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview

11.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction

11.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2019-2024)

11.4.5 Teva Pharmaceuticals Industries Ltd. Recent Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction

11.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2019-2024)

11.5.5 Johnson & Johnson Recent Developments

11.6 Pfizer Inc.

11.6.1 Pfizer Inc. Company Details

11.6.2 Pfizer Inc. Business Overview

11.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction

11.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2019-2024)

11.6.5 Pfizer Inc. Recent Developments

11.7 Bayer AG

11.7.1 Bayer AG Company Details

11.7.2 Bayer AG Business Overview

11.7.3 Bayer AG Prostate Cancer Medicine Introduction

11.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2019-2024)

11.7.5 Bayer AG Recent Developments

11.8 Abbott Laboratories

11.8.1 Abbott Laboratories Company Details

11.8.2 Abbott Laboratories Business Overview

11.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction

11.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2019-2024)

11.8.5 Abbott Laboratories Recent Developments

11.9 Astellas Pharma Inc.

11.9.1 Astellas Pharma Inc. Company Details

11.9.2 Astellas Pharma Inc. Business Overview

11.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction

11.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2019-2024)

11.9.5 Astellas Pharma Inc. Recent Developments

11.10 Roche Holding AG

11.10.1 Roche Holding AG Company Details

11.10.2 Roche Holding AG Business Overview

11.10.3 Roche Holding AG Prostate Cancer Medicine Introduction

11.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2019-2024)

11.10.5 Roche Holding AG Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Astrazeneca plc

Active Biotech

Bristol–Myers Squibb

Teva Pharmaceuticals Industries Ltd

Johnson & Johnson

Pfizer Inc

Bayer

Abbott Laboratories

Astellas Pharma Inc

Roche Holding AG

List of Tables

Table 1. Global Prostate Cancer Medicine Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of LHRH Antagonists

Table 3. Key Players of LHRH Analogs

Table 4. Key Players of Antiandrogens

Table 5. Key Players of Pipeline Drugs for Hormonal Therapy

Table 6. Global Prostate Cancer Medicine Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Prostate Cancer Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Prostate Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Prostate Cancer Medicine Market Share by Region (2019-2024)

Table 10. Global Prostate Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Prostate Cancer Medicine Market Share by Region (2025-2030)

Table 12. Prostate Cancer Medicine Market Trends

Table 13. Prostate Cancer Medicine Market Drivers

Table 14. Prostate Cancer Medicine Market Challenges

Table 15. Prostate Cancer Medicine Market Restraints

Table 16. Global Prostate Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Prostate Cancer Medicine Revenue Share by Players (2019-2024)

Table 18. Global Top Prostate Cancer Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2023)

Table 19. Global Prostate Cancer Medicine Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Prostate Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Prostate Cancer Medicine, Headquarters and Area Served

Table 22. Global Key Players of Prostate Cancer Medicine, Product and Application

Table 23. Global Key Players of Prostate Cancer Medicine, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Prostate Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Prostate Cancer Medicine Revenue Market Share by Type (2019-2024)

Table 27. Global Prostate Cancer Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Prostate Cancer Medicine Revenue Market Share by Type (2025-2030)

Table 29. Global Prostate Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Prostate Cancer Medicine Revenue Share by Application (2019-2024)

Table 31. Global Prostate Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Prostate Cancer Medicine Revenue Share by Application (2025-2030)

Table 33. North America Prostate Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Prostate Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Prostate Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Prostate Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Prostate Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Prostate Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Prostate Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Prostate Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Prostate Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Prostate Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Prostate Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Prostate Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Prostate Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Prostate Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Prostate Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Prostate Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Prostate Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Prostate Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Prostate Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Prostate Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Prostate Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Prostate Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Prostate Cancer Medicine Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Prostate Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Prostate Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Prostate Cancer Medicine Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 65. AstraZeneca plc Company Details

Table 66. AstraZeneca plc Business Overview

Table 67. AstraZeneca plc Prostate Cancer Medicine Product

Table 68. AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 69. AstraZeneca plc Recent Developments

Table 70. Active Biotech Company Details

Table 71. Active Biotech Business Overview

Table 72. Active Biotech Prostate Cancer Medicine Product

Table 73. Active Biotech Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 74. Active Biotech Recent Developments

Table 75. Bristol Myers-Squibb Company Details

Table 76. Bristol Myers-Squibb Business Overview

Table 77. Bristol Myers-Squibb Prostate Cancer Medicine Product

Table 78. Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 79. Bristol Myers-Squibb Recent Developments

Table 80. Teva Pharmaceuticals Industries Ltd. Company Details

Table 81. Teva Pharmaceuticals Industries Ltd. Business Overview

Table 82. Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Product

Table 83. Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 84. Teva Pharmaceuticals Industries Ltd. Recent Developments

Table 85. Johnson & Johnson Company Details

Table 86. Johnson & Johnson Business Overview

Table 87. Johnson & Johnson Prostate Cancer Medicine Product

Table 88. Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 89. Johnson & Johnson Recent Developments

Table 90. Pfizer Inc. Company Details

Table 91. Pfizer Inc. Business Overview

Table 92. Pfizer Inc. Prostate Cancer Medicine Product

Table 93. Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 94. Pfizer Inc. Recent Developments

Table 95. Bayer AG Company Details

Table 96. Bayer AG Business Overview

Table 97. Bayer AG Prostate Cancer Medicine Product

Table 98. Bayer AG Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 99. Bayer AG Recent Developments

Table 100. Abbott Laboratories Company Details

Table 101. Abbott Laboratories Business Overview

Table 102. Abbott Laboratories Prostate Cancer Medicine Product

Table 103. Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 104. Abbott Laboratories Recent Developments

Table 105. Astellas Pharma Inc. Company Details

Table 106. Astellas Pharma Inc. Business Overview

Table 107. Astellas Pharma Inc. Prostate Cancer Medicine Product

Table 108. Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 109. Astellas Pharma Inc. Recent Developments

Table 110. Roche Holding AG Company Details

Table 111. Roche Holding AG Business Overview

Table 112. Roche Holding AG Prostate Cancer Medicine Product

Table 113. Roche Holding AG Revenue in Prostate Cancer Medicine Business (2019-2024) & (US$ Million)

Table 114. Roche Holding AG Recent Developments

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Prostate Cancer Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Prostate Cancer Medicine Market Share by Type: 2023 VS 2030

Figure 3. LHRH Antagonists Features

Figure 4. LHRH Analogs Features

Figure 5. Antiandrogens Features

Figure 6. Pipeline Drugs for Hormonal Therapy Features

Figure 7. Global Prostate Cancer Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Prostate Cancer Medicine Market Share by Application: 2023 VS 2030

Figure 9. Age Below 55 Case Studies

Figure 10. Age 55-75 Case Studies

Figure 11. Age Above 75 Case Studies

Figure 12. Prostate Cancer Medicine Report Years Considered

Figure 13. Global Prostate Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Prostate Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Prostate Cancer Medicine Market Share by Region: 2023 VS 2030

Figure 16. Global Prostate Cancer Medicine Market Share by Players in 2023

Figure 17. Global Top Prostate Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Medicine as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Prostate Cancer Medicine Revenue in 2023

Figure 19. North America Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Prostate Cancer Medicine Market Share by Type (2019-2030)

Figure 21. North America Prostate Cancer Medicine Market Share by Application (2019-2030)

Figure 22. North America Prostate Cancer Medicine Market Share by Country (2019-2030)

Figure 23. United States Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Prostate Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)

Figure 26. Europe Prostate Cancer Medicine Market Share by Type (2019-2030)

Figure 27. Europe Prostate Cancer Medicine Market Share by Application (2019-2030)

Figure 28. Europe Prostate Cancer Medicine Market Share by Country (2019-2030)

Figure 29. Germany Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Prostate Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)

Figure 36. China Prostate Cancer Medicine Market Share by Type (2019-2030)

Figure 37. China Prostate Cancer Medicine Market Share by Application (2019-2030)

Figure 38. Asia Prostate Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)

Figure 39. Asia Prostate Cancer Medicine Market Share by Type (2019-2030)

Figure 40. Asia Prostate Cancer Medicine Market Share by Application (2019-2030)

Figure 41. Asia Prostate Cancer Medicine Market Share by Region (2019-2030)

Figure 42. Japan Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Size YoY (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Prostate Cancer Medicine Market Share by Country (2019-2030)

Figure 52. Brazil Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Prostate Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. AstraZeneca plc Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 59. Active Biotech Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 60. Bristol Myers-Squibb Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 61. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 62. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 63. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 64. Bayer AG Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 65. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 66. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 67. Roche Holding AG Revenue Growth Rate in Prostate Cancer Medicine Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Prostate Cancer Diagnostics and Treatment Market Research Report 2025

Global Prostate Cancer Nuclear Medicine Diagnostics Market Insights Forecast to 2030

Global Castration Resistant Prostate Cancer Treatment Market Research Report 2024

Global Metastatic Bones Cancer Medication Treatment Market Insights Forecast to 2030

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

Global Cancer Pain Market Insights Forecast to 2030

Global Metastatic Prostate Cancer Treatment Market Research Report 2024

Prostate Cancer Minimally Invasive Surgery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics Solution Market Research Report 2025

Global Advanced Prostate Cancer Drug Market Research Report 2025

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Castration resistant Prostate Cancer Drugs Market Research Report 2025

Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Devices Market Research Report 2025

Global Prostate Cancer Molecular Diagnostics Market Research Report 2024

Global Gallbladder Cancer Therapeutics Market Insights Forecast to 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Prostate Cancer Diagnostics Market Research Report 2025

Global Metastatic Bones Cancer Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions